163 related articles for article (PubMed ID: 35118060)
1. Meclozine Attenuates the MARK Pathway in Mammalian Chondrocytes and Ameliorates FGF2-Induced Bone Hyperossification in Larval Zebrafish.
Takemoto G; Matsushita M; Okamoto T; Ito T; Matsuura Y; Takashima C; Chen-Yoshikawa TF; Ebi H; Imagama S; Kitoh H; Ohno K; Hosono Y
Front Cell Dev Biol; 2021; 9():694018. PubMed ID: 35118060
[TBL] [Abstract][Full Text] [Related]
2. Meclozine facilitates proliferation and differentiation of chondrocytes by attenuating abnormally activated FGFR3 signaling in achondroplasia.
Matsushita M; Kitoh H; Ohkawara B; Mishima K; Kaneko H; Ito M; Masuda A; Ishiguro N; Ohno K
PLoS One; 2013; 8(12):e81569. PubMed ID: 24324705
[TBL] [Abstract][Full Text] [Related]
3. Long-term oral meclozine administration improves survival rate and spinal canal stenosis during postnatal growth in a mouse model of achondroplasia in both sexes.
Funahashi H; Matsushita M; Esaki R; Mishima K; Ohkawara B; Kamiya Y; Takegami Y; Ohno K; Kitoh H; Imagama S
JBMR Plus; 2024 Apr; 8(4):ziae018. PubMed ID: 38544920
[TBL] [Abstract][Full Text] [Related]
4. Meclozine promotes longitudinal skeletal growth in transgenic mice with achondroplasia carrying a gain-of-function mutation in the FGFR3 gene.
Matsushita M; Hasegawa S; Kitoh H; Mori K; Ohkawara B; Yasoda A; Masuda A; Ishiguro N; Ohno K
Endocrinology; 2015 Feb; 156(2):548-54. PubMed ID: 25456072
[TBL] [Abstract][Full Text] [Related]
5. Maternal administration of meclozine for the treatment of foramen magnum stenosis in transgenic mice with achondroplasia.
Matsushita M; Mishima K; Esaki R; Ishiguro N; Ohno K; Kitoh H
J Neurosurg Pediatr; 2017 Jan; 19(1):91-95. PubMed ID: 27767902
[TBL] [Abstract][Full Text] [Related]
6. Clinical dosage of meclozine promotes longitudinal bone growth, bone volume, and trabecular bone quality in transgenic mice with achondroplasia.
Matsushita M; Esaki R; Mishima K; Ishiguro N; Ohno K; Kitoh H
Sci Rep; 2017 Aug; 7(1):7371. PubMed ID: 28785080
[TBL] [Abstract][Full Text] [Related]
7. Meclozine ameliorates bone mineralization and growth plate structure in a mouse model of X‑linked hypophosphatemia.
Kamiya Y; Matsushita M; Mishima K; Ohkawara B; Michigami T; Imagama S; Ohno K; Kitoh H
Exp Ther Med; 2023 Jan; 25(1):39. PubMed ID: 36569439
[TBL] [Abstract][Full Text] [Related]
8. Expression of fibroblast growth factor receptor 3 by fibroblast growth factor 2 in cultured chick embryo chondrocytes.
Suh JY; Kim YS; Park JW; Sonn JK; Kim WT
Cell Biol Int; 2005 Mar; 29(3):203-12. PubMed ID: 15878293
[TBL] [Abstract][Full Text] [Related]
9. Bisindolylmaleimide I suppresses fibroblast growth factor-mediated activation of Erk MAP kinase in chondrocytes by preventing Shp2 association with the Frs2 and Gab1 adaptor proteins.
Krejci P; Masri B; Salazar L; Farrington-Rock C; Prats H; Thompson LM; Wilcox WR
J Biol Chem; 2007 Feb; 282(5):2929-36. PubMed ID: 17145761
[TBL] [Abstract][Full Text] [Related]
10. C-Type Natriuretic Peptide Analog as Therapy for Achondroplasia.
Legeai-Mallet L
Endocr Dev; 2016; 30():98-105. PubMed ID: 26684019
[TBL] [Abstract][Full Text] [Related]
11. Constitutive activation of MEK1 in chondrocytes causes Stat1-independent achondroplasia-like dwarfism and rescues the Fgfr3-deficient mouse phenotype.
Murakami S; Balmes G; McKinney S; Zhang Z; Givol D; de Crombrugghe B
Genes Dev; 2004 Feb; 18(3):290-305. PubMed ID: 14871928
[TBL] [Abstract][Full Text] [Related]
12. Circulatory CNP Rescues Craniofacial Hypoplasia in Achondroplasia.
Yamanaka S; Nakao K; Koyama N; Isobe Y; Ueda Y; Kanai Y; Kondo E; Fujii T; Miura M; Yasoda A; Nakao K; Bessho K
J Dent Res; 2017 Dec; 96(13):1526-1534. PubMed ID: 28644737
[TBL] [Abstract][Full Text] [Related]
13. Complementary antagonistic actions between C-type natriuretic peptide and the MAPK pathway through FGFR-3 in ATDC5 cells.
Ozasa A; Komatsu Y; Yasoda A; Miura M; Sakuma Y; Nakatsuru Y; Arai H; Itoh N; Nakao K
Bone; 2005 Jun; 36(6):1056-64. PubMed ID: 15869918
[TBL] [Abstract][Full Text] [Related]
14. Platelet factor 4 inhibits FGF2-induced endothelial cell proliferation via the extracellular signal-regulated kinase pathway but not by the phosphatidylinositol 3-kinase pathway.
Sulpice E; Bryckaert M; Lacour J; Contreres JO; Tobelem G
Blood; 2002 Nov; 100(9):3087-94. PubMed ID: 12384403
[TBL] [Abstract][Full Text] [Related]
15. Interaction of fibroblast growth factor and C-natriuretic peptide signaling in regulation of chondrocyte proliferation and extracellular matrix homeostasis.
Krejci P; Masri B; Fontaine V; Mekikian PB; Weis M; Prats H; Wilcox WR
J Cell Sci; 2005 Nov; 118(Pt 21):5089-100. PubMed ID: 16234329
[TBL] [Abstract][Full Text] [Related]
16. An RNA aptamer restores defective bone growth in FGFR3-related skeletal dysplasia in mice.
Kimura T; Bosakova M; Nonaka Y; Hruba E; Yasuda K; Futakawa S; Kubota T; Fafilek B; Gregor T; Abraham SP; Gomolkova R; Belaskova S; Pesl M; Csukasi F; Duran I; Fujiwara M; Kavkova M; Zikmund T; Kaiser J; Buchtova M; Krakow D; Nakamura Y; Ozono K; Krejci P
Sci Transl Med; 2021 May; 13(592):. PubMed ID: 33952673
[TBL] [Abstract][Full Text] [Related]
17. Basic fibroblast growth factor as a selective inducer of matrix Gla protein gene expression in proliferative chondrocytes.
Stheneur C; Dumontier MF; Guedes C; Fulchignoni-Lataud MC; Tahiri K; Karsenty G; Corvol MT
Biochem J; 2003 Jan; 369(Pt 1):63-70. PubMed ID: 12230429
[TBL] [Abstract][Full Text] [Related]
18. Delayed bone age due to a dual effect of FGFR3 mutation in Achondroplasia.
Pannier S; Mugniery E; Jonquoy A; Benoist-Lasselin C; Odent T; Jais JP; Munnich A; Legeai-Mallet L
Bone; 2010 Nov; 47(5):905-15. PubMed ID: 20673820
[TBL] [Abstract][Full Text] [Related]
19. NGF increases FGF2 expression and promotes endothelial cell migration and tube formation through PI3K/Akt and ERK/MAPK pathways in human chondrocytes.
Yu X; Qi Y; Zhao T; Fang J; Liu X; Xu T; Yang Q; Dai X
Osteoarthritis Cartilage; 2019 Mar; 27(3):526-534. PubMed ID: 30562625
[TBL] [Abstract][Full Text] [Related]
20. Electrical stimulation facilitates the angiogenesis of human umbilical vein endothelial cells through MAPK/ERK signaling pathway by stimulating FGF2 secretion.
Geng K; Wang J; Liu P; Tian X; Liu H; Wang X; Hu C; Yan H
Am J Physiol Cell Physiol; 2019 Aug; 317(2):C277-C286. PubMed ID: 30995109
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
